Anika Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Anika Therapeutics using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $0.04 | $-0.06 | 166.7 % |
| Q2 | 2025-07-30 | $-0.13 | $-0.21 | 38.1 % |
| Q1 | 2025-05-09 | $-0.06 | $0.09 | -166.7 % |
| Q4 | 2025-03-12 | $-0.03 | $0.09 | -133.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $27.80M | $27.80M | 0.00 % |
| Q2 | 2025-07-30 | $28.22M | $27.04M | 4.29 % |
| Q1 | 2025-05-09 | $26.20M | $28.07M | -6.66 % |
| Q4 | 2025-03-12 | $30.60M | $29.00M | 5.52 % |
Anika Therapeutics (ANIK) is scheduled to report earnings on March 11, 2026. The last reported earnings were for reported on November 5, 2025 for Q3.
The Actual EPS was $0.04, which beat the estimate of $-0.06.
The Actual Revenue was $27.8M, which hit the estimate of $27.8M.
Browse earnings estimates, EPS, and revenue on all stocks.